Covalis Capital’s Eastman Chemical EMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-133,309
Closed -$12M 60
2022
Q2
$12M Sell
133,309
-27,379
-17% -$2.83M 2.3% 12
2022
Q1
$18M Sell
160,688
-67,784
-30% -$7.94M 4.9% 4
2021
Q4
$27.6M Buy
+228,472
New +$25.4M 10.09% 2

Other funds holding EMN

Covalis Capital's EMN Position: Q3 2022 in Review

Covalis Capital sold out of Eastman Chemical (EMN) in Q3 2022, closing a stake of 133,309 shares — an estimated $12M sold.

Covalis Capital first reported a position in EMN in Q4 2021 and held it in 3 quarters. The position peaked at $27.6M in Q4 2021. 656 funds tracked by Wall St. Rank hold EMN as of Q3 2022.

  • Covalis Capital reported no remaining Eastman Chemical position as of Q3 2022 after selling out during the quarter.
  • Covalis Capital sold 133,309 Eastman Chemical shares in Q3 2022, an estimated $12M.
  • Covalis Capital first reported a position in Eastman Chemical in Q4 2021 and held it in 3 quarters.
  • Covalis Capital's Eastman Chemical position peaked at $27.6M in Q4 2021.
  • 656 funds tracked by Wall St. Rank held Eastman Chemical as of Q3 2022.

Based on Covalis Capital's 13F filing for Q3 2022, filed 14 Nov 2022.